Charles Russell Speechlys advises University College London Hospitals Charities on the sale of Inventive Medical limited
Charles Russell Speechlys has advised the University College London Hospitals Charities on the sale of Inventive Medical limited (IML), a UK company which is the global supplier of cardio ultrasound simulation products under the HeartWorks brand, to AIM-listed MedaPhor Group plc, the global provider of advanced ultrasound skills training simulators for medical professionals.
Leading cardiac anaesthesiologists at University College London Hospital developed IML’s HeartWorks simulators and online training materials. These are recognised as one of the most true-to-life and comprehensive simulation tools for Transthoracic and Transoesophageal echocardiography training.
The University College London Hospitals Charities and certain option holders entered into a sale and purchase agreement on 2 August 2016 with MedaPhor to sell IML and the benefit of certain shareholder loans owed by IML. The consideration will be satisfied by the issue of new Ordinary Shares in MedaPhor, representing 20% of its enlarged share capital.
Ian Whittaker, CEO of IML said, “It is tremendously exciting that Inventive Medical will now be part of the MedaPhor Group and without doubt, great news for customers. Together, we look forward to sharing our expertise in simulation practice and continuing to drive innovation in ultrasound education for the benefit of clinicians needing to develop competence in such skills and ultimately the patients they will serve. ”
Philip Brading, from University College London Hospitals Charities, said “We are delighted to be selling IML to MedaPhor when the potential synergies between the two businesses are so great. We are therefore pleased to continue to retain an interest in its success through our shareholding in the merged business and are thankful to Charles Russell Speechlys for how excellently they executed the transaction for us. ”
Hamish Perry, lead partner at Charles Russell Speechlys, said “We are pleased to have been involved in this exciting merger. It is great to see another successful business being born out of this leading University and we are pleased to be a part of its growth journey. ”
The team at Charles Russell Speechlys was led by Corporate Partner, Hamish Perry, who was assisted by Tom Smitham, Fiona Walsh, Laura Melody and Helen Hutchinson (Corporate) and Caroline Young (Intellectual Property).
Sponsor Licence Compliance: Key considerations & how to be audit ready
Join us for the third in our series of mini webinars on post Brexit immigration about sponsor licence compliance.
Dual class share structures: how do they work and what are the pros and cons?
Dual class share structures allow a shareholder, for example the founder, to retain voting control over a company.
COVID-19 Vaccination – can an employer make it compulsory for employees?
We review what legal issues to take into account when considering to make vaccination compulsory as an employer.
The Lawyer, New Law Journal, International Adviser, CDR Magazine and eprivateclient report on the firm's partner promotions
Charles Russell Speechlys promoted five lawyers to partner, effective 1 May 2021.
Linking ESG and Executive Pay
How does a business go about embedding a focus on strong ESG performance into the structures and culture of its organisation?
National Security and Investment Act granted Royal Assent
The Act establishes a new regime for the review of mergers, acquisitions and other transactions that could threaten national security.
Charles Russell Speechlys advises Waverton on acquisition of Cornerstone Asset Management
Established in July 2010 and with offices in Edinburgh and Glasgow, Cornerstone offers wealth management and financial planning advice.
Charles Russell Speechlys promotes five to Partner
The promotions are effective 1 May 2021 and are accompanied by one Legal Director and 15 Senior Associate promotions.
Proposed Takeover Code Amendments – Key Changes
The Consultation Paper has now been followed by a corresponding response paper which made certain modifications to the initial proposals.
Charles Russell Speechlys advises Fudco Partnership on sale to Exponent-backed Vibrant Foods
Fudco is a family-owned business selling South Asian ethnic foods in UK and Europe.
Charles Russell Speechlys advises Polar Technology on investment by BGF
Polar Technology Management Group is a holding company for engineering businesses operating at the leading edge of technology.
Use and Regulation of Renewable Energy Certificates in the UAE
The market for trading in renewable energy certificates is set to increase in both visibility and importance.
Odey and Hffx: partnerships with mixed membership
Examining two decisions relating to remuneration arrangements in partnerships with individual and corporate membership.
Charles Russell Speechlys advises shareholders of Modern Networks on sale to Horizon Capital
Modern Networks is a leading provider of IT support, broadband and telecoms managed services to the UK’s commercial property sector.
Patrick Gearon FCIArb
Insolvency Legislation in the GCC
The interesting times of the last 14 months were preceded by the interesting times of the financial crisis of 2008/2009.
Charles Russell Speechlys advises on Trident Royalties’ US$28m Placing
Trident Royalties plc is a growth-focused mining royalty and streaming company.
Charles Russell Speechlys advises Avation plc on £7.5m secondary placing
Headquartered in Singapore, Avation plc manages a fleet of aircraft which it leases to airlines across the world.
The Corporate team's involvement in Fishawack Health’s acquisition of PRMA featured in Yahoo! Finance USA, Markets Insider and Morning Star
Martin Wright and the Corporate team provided legal support on the acquisition of PRMA Consulting.
Charles Russell Speechlys, Strategic Partners of the Asoko Insight West Africa's Family-Owned Business Report
The report is the most comprehensive study of Family-Owned Businesses throughout West Africa.
Jessica Arrol quoted by Real Deals on the implementation of SFDR
SFDR aims to remove greenwashing and promote transparency in reporting ESG, but GPs and LPs are experiencing its flaws.